in serum from 11 out of 18 patients with primary hypothyroidism that blocked the increase in cyclic adenosine monophosphate stimulated by bovine thyroid stimulating hormone in cultured thyroid adenoma cells.11 Our findings may be of greater clinical relevance as whole serum, not just the IgG fraction, was examined and secretion of thyroid hormone by thyroid tissue was measured; this is the first report of a direct inhibitory effect on such secretion.
The clinical importance of this blocking effect found in vitro needs to be assessed further, but it is probably an important factor contributing to the pathogenesis of some cases of primary hypothyroidism. 
Results
In all five girls serum IgA concentrations fell after treatment with thyroxine was started (figure) . In four of them IgA concentrations fell below the range of normal for healthy British children.2 In one child the serum IgA concentration fell to less than 0-01 g/l and remained reduced. IgA concentrations returned to normal in the other four and then increased with age in the usual way. Concentrations of IgG and IgM generally fluctuated within the normal range during treatment; one child, however, had a marginally low IgG concentration at seven months, and three children developed marginally raised IgM concentrations between 18 months and three years after the start of treatment.
The child who developed long lasting IgA deficiency subsequently did not show any evidence of recurrent infection or allergic disease. Four years after the start of treatment with thyroxine her serum gave a negative result when tested for thyroid microsomal and colloid antibodies.
Discussion
Physical and intellectual development are delayed in children with infantile hypothyroidism. The development of their immune systems and particularly of IgA concentrations, which normally rise with age, might also be expected to be delayed. Before treatment, however, four of the five children had IgA concentrations that lay within the normal range.
The early fall in IgA concentration after the start of treatment with thyroxine was unexpected. There is no reason to suppose that a return to normal metabolism will lead to a redistribution of IgA within the body. The fall in IgA concentration is unlikely to have been due to a non-specific increase in catabolism as IgA has a shorter half life than IgG or IgM and should therefore be the least affected class of immunoglobulins. Free monomeric hepatitis B virus DNA was found in three patients positive for hepatitis Be antigen (HBeAg) and one positive for anti-HBe, and integrated hepatitis B virus DNA was present in four patients positive for anti-HBe. In two other patients the small size of the samples did not allow a distinction between free and integrated viral DNA. The state of the virus in the mononuclear cells seemed to correlate with the HBeAg or anti-HBe state, as has been noted in the liver.
These results indicate that hepatitis B virus may infect mononuclear blood cells, thereby expanding the tissue specificity of this agent beyond the liver, as has been reported for pancreatic, kidney, and skin tissue. They also suggest that hepatitis B virus infection of mononuclear cells might be related to immunological abnormalities observed in carriers of the virus.
Introduction
Immunological abnormalities are often present in patients infected with hepatitis B virus and may be responsible for
